Use of D-allose as an immunosuppressive agent

Details Use of D-allose as an immunosuppressive agent Use of D-allose as an immunosuppressive agent

1994-08-15

1997-04-15

Peselev, Elli

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 111, A61K 3170

Patent

active

056209606

ABSTRACT:
D-allose has been found to substantially inhibit segmented neutrophil production and to lower platelet counts during in vivo trials, without other significant detrimental clinical effects. Such pharmacological activity makes D-allose a good candidate for treatment, either alone or as an adjuvant, of such conditions as chronic myelogenous leukemia. It also holds promise in reducing thrombus formation during post-operative periods, especially in combination with other anti-clotting drugs.

REFERENCES:
patent: 4963382 (1990-10-01), Arena et al.

Affiliated with

Also associated with

Rating

Use of D-allose as an immunosuppressive agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of D-allose as an immunosuppressive agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of D-allose as an immunosuppressive agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-360802